Salarius Pharmaceuticals (SLRX) SEC Filings & 10K Form → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free SLRX Stock Alerts $0.48 -0.03 (-6.10%) (As of 11:26 AM ET) Add Compare Share Share SEC FilingsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Recent Salarius Pharmaceuticals SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView04/12/20243:50 PMArthur David J. (Reporting)Salarius Pharmaceuticals, Inc. (Issuer)Salarius Pharmaceuticals (Issuer)Form 4Statement of changes in beneficial ownership of securities 03/26/20243:03 PMSalarius Pharmaceuticals, Inc. (Filer)Salarius Pharmaceuticals (Filer)Form DEF 14A03/26/20243:05 PMSalarius Pharmaceuticals, Inc. (Filer)Salarius Pharmaceuticals (Filer)Form DEFA14A03/15/20244:00 PMSalarius Pharmaceuticals, Inc. (Filer)Salarius Pharmaceuticals (Filer)Form PRE 14A02/22/20243:16 PMLammers Paul (Reporting)Salarius Pharmaceuticals, Inc. (Issuer)Salarius Pharmaceuticals (Issuer)Form 4Statement of changes in beneficial ownership of securities 02/22/20243:21 PMLieber Jonathan I (Reporting)Salarius Pharmaceuticals, Inc. (Issuer)Salarius Pharmaceuticals (Issuer)Form 4Statement of changes in beneficial ownership of securities 09/06/20234:09 PMSalarius Pharmaceuticals, Inc. (Filer)Salarius Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/12/20238:22 AMSalarius Pharmaceuticals, Inc. (Filer)Salarius Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/07/202311:15 PMSalarius Pharmaceuticals, Inc. (Filer)Salarius Pharmaceuticals (Filer)Form EFFECT06/07/20236:27 AMSalarius Pharmaceuticals, Inc. (Filer)Salarius Pharmaceuticals (Filer)Form 424B306/01/20234:01 PMSalarius Pharmaceuticals, Inc. (Filer)Salarius Pharmaceuticals (Filer)Form S-3/A05/25/20232:12 PMSalarius Pharmaceuticals, Inc. (Filer)Salarius Pharmaceuticals (Filer)Form DNotice of Exempt Offering of Securities 05/11/20237:29 AMSalarius Pharmaceuticals, Inc. (Filer)Salarius Pharmaceuticals (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/01/20237:02 AMSalarius Pharmaceuticals, Inc. (Filer)Salarius Pharmaceuticals (Filer)Form DEF 14A05/01/20237:04 AMSalarius Pharmaceuticals, Inc. (Filer)Salarius Pharmaceuticals (Filer)Form DEFA14A(Data available from 1/1/2016 forward) Related Companies and Tools Related Companies: HSTO 10Q Form NTBL 10Q Form CYCC 10Q Form CNSP 10Q Form CMND 10Q Form BPTH 10Q Form CWBR 10Q Form LSDI 10Q Form QLGN 10Q Form INM 10Q Form SEC Filings Tools: Latest SEC FilingsInsider Trading Activity This page (NASDAQ:SLRX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salarius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
